About Us
Submissions
Advertising
SIGN IN
|
SUBSCRIBE
Issue
Recently Published
Current
Archive
Supplements
Events
JADPRO Live
JADPRO Workshop
CE
Patient Ed
Special Content
Resource Centers
Multiple Myeloma
Biomarkers in NSCLC
Bone Protection
CAR-T
Chronic Lymphocytic Leukemia
DLBCL
GVHD
Metastatic HER2+ Breast Cancer
Metastatic Triple-Negative Breast Cancer
MPN
Renal Cell Carcinoma
Roundtable Series
BCL-2 Inhibition in CLL
Follicular Lymphoma
Early-Stage Multiple Myeloma
BTKi in CLL: Update
BTKi in CLL
HR+/HER2- Breast Cancer
HER2-mutant NSCLC
CLL and COVID
Multiple Myeloma
R/R Multiple Myeloma
Bone Health
Myelofibrosis
Updates
Cardio-Oncology
Benign Hematology
Expert Conversations
Clinical Case Series
APSHO Educator Modules
JADPRO Live Spotlights
Highlights
Podcast
Society
Editorial
Advanced Practitioners in Hematology and Oncology: A Call to Action
Sandra Kurtin, PhD, ANP-BC, AOCN®, FAPO, Guest Editor
Read More
Research and Scholarship
Advanced Practitioners in Hematology and Oncology: State of the Workforce
Sandra Kurtin,(1) PhD, ANP-BC, AOCN®, FAPO, Carolyn Grande,(2) CRNP, AOCNP®, Megan May,(3) PharmD, BCOP, FAPO, FHOPA, Andrea Edwards,(4) PA-C, Steven Wei,(5) EdD, MS, MPH, PA-C, DFAPPA, Brianna Hoffner,(6) MSN, ANP-BC, AOCNP®, FAPO, and Wendy Vogel,(7) MSN, FNP, AOCNP®, FAPO
Read More
Research and Scholarship
The Value of the Advanced Practitioner in Hematology and Oncology: Establishing Benchmarks
Sandra Kurtin,(1) PhD, ANP-BC, AOCN®, FAPO, Mailey L. Wilks,(2) DNP, APRN-CNP, Heather Koniarczyk,(2) MSN, APRN-CNP, AOCNP®, Nicole Deline,(3) MSN, APRN, FNP-C, AOCNP®, Sara Toth,(4) FNP-C, AOCNP®, AGN-BC, Andrea Edwards,(5) PA-C, Scott Rowley,(6) DNP, APRN-CNP, AOCNP®, Jason Astrin,(7) DMSc, MBA, PA-C, DFAAPA, and Wendy Vogel,(8) MSN, FNP, AOCNP®, FAPO
Read More
Review Article
Understanding Advanced Practitioner Prescriptive Privileges for Anticancer Therapies: A National Survey
Archana Ajmera,(1) MSN, ANP-BC, AOCNP®, Leigh Boehmer,(2) PharmD, BCOP, Christa Marie Braun-Inglis,(3) DNP, APRN, FNP-BC, AOCNP®, Brianna Hoffner,(4) MSN, ANP-BC, AOCNP®, FAPO, Maria Matta,(2) MPH, and Rana R. McKay,(1) MD
Read More
Review Article
Advanced Practitioners as Agents of Change: Leveraging Quality Improvement to Improve Practice
Sandra Kurtin,(1) PhD, ANP-BC, AOCN®, FAPO, Andrea Edwards,(2) PA-C, Heather Koniarczyk,(3) MSN, APRN-CNP, AOCNP®, Camille Petraitis,(4) DNP, FNP-BC, Lisa Nodzon,(5) PhD, APRN, AOCNP®, Nicole Deline,(6) MSN, APRN, FNP-C, AOCNP®, Tajuana Bradley,(7) FNP-BC, Megan May,(8) PharmD, BCOP, FAPO, FHOPA, Molly Thompson-Coffey,(9) Jessica Tamasi,(9) and Wendy Vogel,(10) MSN, FNP, AOCNP®, FAPO
Read More
Review Article
Role of the Advanced Practitioner in Clinical Research
Christa Marie Braun-Inglis,(1) DNP, APRN, FNP-BC, AOCNP®, Brianna Hoffner,(2) MSN, ANP-BC, AOCNP®, FAPO, Lisa Kottschade,(3) APRN, MSN, CNP, FAPO, Erin Pierce,(4) MSN, APRN, FNP-C, and Sandra Kurtin,(5) PhD, ANP-BC, AOCN®, FAPO
Read More
Review Article
APSHO Oncology/Hematology Advanced Practitioner Compensation Survey
Wendy Vogel,(1) MSN, FNP, AOCNP®, FAPO, Yi Lisa Hwa,(2) APRN, DNP, CNP, FAPO, Lisa Kottschade,(2) APRN, MSN, CNP, FAPO, and Megan May,(3) PharmD, BCOP, FAPO, FHOPA
Read More
Meeting Report
Racial Disparities, Advanced Ovarian Cancer, and HER2 Expression: 2023 ASCO Annual Meeting Highlights for the Advanced Practitioner
Andrew S. Guinigundo, MSN, RN, CNP, ANP-BC
Read More
Meeting Report
Early-Stage Breast Cancer, EGFR-Mutated NSCLC, and High-Risk Melanoma: 2023 ASCO Annual Meeting Highlights for the Advanced Practitioner
Lisa Kottschade, APRN, MSN, CNP, FAPO
Read More
Meeting Report
Relapsed/Refractory Multiple Myeloma, DLBCL, and CLL: 2023 ASCO Annual Meeting Highlights for the Advanced Practitioner
Oxana Megherea, PharmD, BCOP
Read More
Review Article
Revolutionizing Cancer Treatment: Harnessing the Power of Biomarkers to Improve Patient Outcomes
Donald C. Moore,(1) PharmD, BCPS, BCOP, DPLA, FCCP, and Andrew S. Guinigundo,(2) MSN, RN, CNP, ANP-BC
Read More
Review Article
Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine
Donald C. Moore,(1) PharmD, BCPS, BCOP, DPLA, FCCP, and Andrew S. Guinigundo,(2) MSN, RN, CNP, ANP-BC
Read More
Review Article
The Role of Biomarkers in Guiding Clinical Decision-Making in Oncology
Donald C. Moore,(1) PharmD, BCPS, BCOP, DPLA, FCCP, and Andrew S. Guinigundo,(2) MSN, RN, CNP, ANP-BC
Read More
Review Article
The Advanced Practitioner’s Role in the Rapidly Evolving Landscape of Precision Medicine
Donald C. Moore,(1) PharmD, BCPS, BCOP, DPLA, FCCP, and Andrew S. Guinigundo,(2) MSN, RN, CNP, ANP-BC
Read More
Continuing Education
Continuing Education Information: Multiple Myeloma and Plasma Cell Disorders: Update on Diagnosis, Prognosis, Treatment, and Supportive Care
Read More
Editorial
Introduction
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, and Tiffany Richards, PhD, ANP-BC, AOCNP®
Read More
Grand Rounds
A Focus on Newly Diagnosed Multiple Myeloma
Kevin Brigle,(1) PhD, ANP, Daniel Verina,(2) DNP, RN, ACNP-BC, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN
Read More
Grand Rounds
A Focus on Relapsed Multiple Myeloma
Kimberly Noonan,(1) DNP, ANP-BC, AOCN®, Sandra Rome,(2) RN, MN, AOCN®, CNS, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN
Read More
Grand Rounds
A Focus on Special Populations in Relapsed Multiple Myeloma
Mary Steinbach,(1) DNP, APRN, Kathleen Colson,(2) RN, BSN, BS, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN
Read More
Grand Rounds
A Focus on CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma
Donna Catamero, ANP-BC, OCN®, CCRC, Tiffany Richards, PhD, ANP-BC, AOCNP®, and Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN
Read More
Grand Rounds
A Focus on Waldenström Macroglobulinemia and AL Amyloidosis
Rebecca Lu, MS, FNP, and Tiffany Richards, PhD, ANP-BC, AOCNP®
Read More
Continuing Education
Continuing Education Information: Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life
Read More
Review Article
Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life
Miguel A. Escobar,(1) MD, Cindy Leissinger,(2) MD, and Guy Young,(3) MD
Read More
Editorial
Incorporating Scientific Advances and Improving Access to Care: Meeting Abstracts From the 2021 ASH Annual Meeting and Exposition
Sandra E. Kurtin, PhD, ANP-C, AOCN®
Read More
Meeting Abstract
ASH Highlights and Commentary: Multiple Myeloma
Kathryn T. Maples, PharmD, BCOP
Read More
Meeting Abstract
ASH Highlights and Commentary: Myeloid Malignancies
Lindsey Lyle, MS, PA-C
Read More
Meeting Abstract
ASH Highlights and Commentary: Additional Topics of Interest
Sandra E. Kurtin, PhD, ANP-C, AOCN®
Read More
Editorial
The Advanced Practitioner’s Role in Treating Patients With Hematologic Malignancies: Highlights From SOHO 2021
Alexis C. Geppner, MLS, CTTS, MPAS, PA-C, Guest Editor
Read More
Meeting Report
Beyond Hyper-CVAD in ALL: Highlights From SOHO 2021
Alexis C. Geppner, MLS, CTTS, PA-C
Read More
Meeting Report
IDH-Mutated AML: Beyond Enasidenib and Ivosidenib Monotherapy: Highlights From SOHO 2021
Alexis C. Geppner, MLS, CTTS, PA-C
Read More
Meeting Report
Targeting p53 in MDS: Highlights From SOHO 2021
Alexis C. Geppner, MLS, CTTS, PA-C
Read More
Meeting Report
Updates on Clinical Trials for Myelofibrosis: Highlights From SOHO 2021
Lisa Nodzon, PhD, APRN, AOCNP®
Read More
Meeting Report
Therapeutic Updates for Richter Syndrome: Highlights From SOHO 2021
Lisa Nodzon PhD, APRN, AOCNP®
Read More
Meeting Report
BCMA-Directed CAR T Cells in Relapsed Refractory Multiple Myeloma: Highlights From SOHO 2021
Lisa Nodzon PhD, APRN, AOCNP®
Read More
Meeting Report
Immunotherapy Approaches in T-Cell Lymphoma: Highlights From SOHO 2021
Kelly Valla, PharmD, BCOP
Read More
Meeting Report
The Next Wave of Novel Agents in Aggressive B-Cell Lymphoma: Highlights From SOHO 2021
Kelly Valla, PharmD, BCOP
Read More
Meeting Report
Novel Treatment Approaches in Relapsed/Refractory Mantle Cell Lymphoma: Highlights From SOHO 2021
Kelly Valla, PharmD, BCOP
Read More
Review Article
CDK4/6 Inhibitors: Paving the Way for HR-Positive, HER2-Negative Early Breast Cancer
Kristi Orbaugh,(1) RN, MSN, RNP, AOCN®, Val R. Adams,(2) PharmD, FCCP, BCOP, FHOPA, and Theresa W. Gillespie,(3) PhD, MA, RN, FAAN
Read More
Editorial
Reimagining Medical Education: Selected Abstracts From the 2020 ASH Meeting
Sandra E. Kurtin, PhD, ANP-C, AOCN®
Read More
Meeting Abstract
ASH Highlights and Commentary: Multiple Myeloma
Read More
Meeting Abstract
ASH Highlights and Commentary: Chronic Lymphocytic Leukemia and Lymphomas
Read More
Meeting Abstract
ASH Highlights and Commentary: Additional Topics of Interest
Read More
Editorial
The Status of Chemotherapy in Metastatic Breast Cancer: Insights for the Advanced Practitioner
Kirollos Hanna,(1) PharmD, BCPS, BCOP, and Kelley Mayden,(2) MSN, FNP, AOCNP®
Read More
Review Article
Chemotherapy Treatment Considerations in Metastatic Breast Cancer
Kirollos Hanna,(1) PharmD, BCPS, BCOP, and Kelley Mayden,(2) MSN, FNP, AOCNP®
Read More
Review Article
The Use of Real-World Evidence for Oral Chemotherapies in Breast Cancer
Kirollos Hanna,(1) PharmD, BCPS, BCOP, and Kelley Mayden,(2) MSN, FNP, AOCNP®
Read More
Editorial
The Advanced Practitioner’s Role in Treating Patients With Hematologic Malignancies: Highlights From SOHO 2020
Allyson Price, MPAS, PA-C, Guest Editor
Read More
Meeting Report
Predicting Drug Response in Acute Lymphoblastic Leukemia: Highlights From SOHO 2020
Allyson Price, MPAS, PA-C
Read More
Meeting Report
Immunotherapy for T-Cell ALL and T-NHL: Highlights From SOHO 2020
Allyson Price, MPAS, PA-C
Read More
Meeting Report
Oral Hypomethylating Agents for Myelodysplastic Syndromes: Highlights From SOHO 2020
Allyson Price, MPAS, PA-C
Read More
Meeting Report
Emerging Therapies in Myelofibrosis: Highlights From SOHO 2020
Lisa Nodzon, PhD, ARNP, AOCNP®
Read More
Meeting Report
Updates on Therapeutic Advancements in Relapsed or Refractory Multiple Myeloma: Highlights From SOHO 2020
Lisa Nodzon, PhD, APRN, AOCNP®
Read More
Meeting Report
Minimal Residual Disease in Chronic Lymphocytic Leukemia: Highlights From SOHO 2020
Lisa Nodzon, PhD, ARNP, AOCNP®
Read More
Meeting Report
Integrating Novel Agents in Relapsed or Refractory Hodgkin Lymphoma: Highlights From SOHO 2020
Kelly Valla, PharmD, BCOP
Read More
Meeting Report
Managing Relapsed Disease in Peripheral T-Cell Lymphoma: Highlights From SOHO 2020
Kelly Valla, PharmD, BCOP
Read More
Meeting Report
New CAR Designs: Highlights From SOHO 2020
Kelly Valla, PharmD, BCOP
Read More
Editorial
Managing Thrombosis in Polycythemia Vera: The Advanced Practitioner Perspective
Lindsey Lyle, MS, PA-C, Guest Editor
Read More
Grand Rounds
Budd-Chiari Syndrome as Initial Manifestation of Polycythemia Vera: Complexities in the Management of Younger Patients
Lindsey Lyle,(1) MS, PA-C, and Lindsey E. Kalhagen,(2) PA
Read More
Grand Rounds
Optimizing Treatment Strategies in Patients With Polycythemia Vera Who Develop a Thrombotic Event on Frontline Therapy
Lindsey Lyle,(1) MS, PA-C, and Julie Huynh-Lu,(2) PA
Read More
Editorial
The Advanced Practitioner’s Role in Treating Older Adults With Hematologic Malignancies
Sandra E. Kurtin, PhD, ANP-C, AOCN®
Read More
Meeting Abstract
ASH Highlights and Commentary: Chronic Lymphocytic Leukemia
Read More
Meeting Abstract
ASH Highlights and Commentary: Acute Myeloid Leukemia and Myelodysplastic Syndromes
Read More
Meeting Abstract
ASH Highlights and Commentary: Multiple Myeloma
Read More
Editorial
Acute Myeloid Leukemia: An Ever-Changing Disease
Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C
Read More
Review Article
Optimizing Use of Newly Approved Agents for Acute Myeloid Leukemia
Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C
Read More
Review Article
The Role of the Advanced Practitioner in Enhancing Outcomes
Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C
Read More
Appendix
Appendix: Key Information on Newly Approved AML Drugs
Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C
Read More
Editorial
CAR T-Cell Therapy for Large B-Cell Lymphoma
Maritza C. Alencar, DNP, MBA, APRN-BC, BMTCN®
Read More
Review Article
Anti-CD19 CAR T-Cell Therapy for Adult Patients With Refractory Large B-Cell Lymphoma
Kathleen McDermott, RN, BSN, OCN®, BMTCN®, and Lauren Spendley, AGNP, MSN, AOCN®
Read More
Review Article
CAR T-Cell Therapy: Adverse Events and Management
Sherry Adkins, RN, MSN, ANP-C
Read More
Review Article
Educating Multidisciplinary Care Teams, Patients, and Caregivers on CAR T-Cell Therapy
Alix Beaupierre, RN, BSN, OCN®, Nicole Kahle, MS, RN, OCN®, BMTCN®, Rachel Lundberg, PA-C, MPAS, and Amy Patterson, MSN, APRN, AOCNS®, BMTCN®
Read More
Editorial
A Letter From the Guest Editor
Sandra E. Kurtin, PhD, ANP-C, AOCN®
Read More
Commentary
ASH Highlights and Commentary: Multiple Myeloma
Josh Epworth, ARNP
Read More
Commentary
ASH Highlights and Commentary: Acute Myeloid Leukemia
Lindsey Lyle, MS, PA-C
Read More
Commentary
ASH Highlights and Commentary: Leukemias and Lymphomas
Sandra E. Kurtin, PhD, ANP-C, AOCN®
Read More
Editorial
Immuno-Oncology Essentials: An Overview
Brianna Hoffner, MSN, ANP-BC, AOCNP®
Read More
Review Article
Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
Brianna Hoffner, MSN, ANP-BC, AOCNP®, and Krista M. Rubin, MS, FNP-BC
Read More
Review Article
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP®
Read More
Review Article
Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
Casey Fazer, PA-C
Read More
Review Article
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
Laura S. Wood, RN, MSN, OCN®
Read More
Appendix
Care Step Pathway Tools for Immune-Related Adverse Event Assessment and Management
Read More
Editorial
A Letter From the Guest Editors
Lisa A. Kottschade, APRN, MSN, CNP, and LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP
Read More
Editorial
A Brighter Future for Patients With Melanoma
Lisa A. Kottschade, APRN, MSN, CNP, and LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP
Read More
Review Article
Diagnosis, Evaluation, and Surgical Management of Melanoma
Brianna Hoffner, MSN, ANP-BC, AOCNP®, and Christan G. Bartsch, MSHS, PA-C, MPH
Read More
Review Article
Harnessing the Immune System in the Treatment of Melanoma
Suzanne McGettigan, MSN, CRNP, AOCN®
Read More
Review Article
BRAF/MEK Inhibition in Melanoma: An Update
Lisa A. Kottschade, APRN, MSN, CNP, and Kathleen M. Madden, RN, MSN, FNP-BC, AOCNP®, APHN
Read More
Review Article
Mutations Beyond BRAF V600
Mollie Reed, MSN, ACNP-BC
Read More
Review Article
Melanomas of Noncutaneous Origin: Diagnosis, Treatment, and Outcomes
Lisa A. Kottschade, APRN, MSN, CNP
Read More
Review Article
Supportive Care and Management of Treatment-Related Adverse Effects From Immune Checkpoint Inhibitors and Targeted Therapies in Melanoma
Krista M. Rubin, MS, FNP-BC, and Lisa A. Kottschade, APRN, MSN, CNP
Read More
Review Article
Drug-Drug Interactions in Melanoma
LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP
Read More
Appendix
Appendix
Compiled by Lisa A. Kottschade, APRN, MSN, CNP
Read More
Editorial
A Letter From the Guest Editors
Sandra E. Kurtin, PhDc, ANP-C, AOCN®, and Ali McBride, PharmD, BCOP
Read More
Continuing Education
Chronic Lymphocytic Leukemia in 2018: What the Advanced Practitioner in Oncology Needs to Know
Sandra E. Kurtin, PhDc, ANP-C, AOCN®, and Ali McBride, PharmD, BCOP
Read More
Review Article
Scientific Advances in the Diagnosis and Risk Stratification of Chronic Lymphocytic Leukemia
Amy Goodrich, MSN, CRNP, and Nina Wagner-Johnston, MD
Read More
Review Article
Monoclonal Antibodies in Chronic Lymphocytic Leukemia
Lindsay Hladnik,(1) PharmD, BCOP, Kristan Augustin,(2) PharmD, BCOP, and Christopher Arp,(3) PharmD
Read More
Review Article
Small Molecules in Chronic Lymphocytic Leukemia: Novel Targets, New Challenges
Sandra E. Kurtin, PhDc, ANP-C, AOCN®, and Ali McBride, PharmD, BCOP
Read More
Review Article
Emerging Therapies in Chronic Lymphocytic Leukemia: Current Trials
Ashley E. Glode, PharmD, BCOP, and Hani M. Babiker, MD
Read More
Review Article
Risk-Adapted Treatment Strategies for Chronic Lymphocytic Leukemia
Lisa Nodzon, PhD, ARNP, AOCNP®, and Javier Pinilla-Ibarz, MD, PhD
Read More
Review Article
Supportive Care and Management of Treatment-Emergent Adverse Events in Chronic Lymphocytic Leukemia
Barbara Barnes Rogers, CRNP, MN, AOCN®, ANP-BC, and Nadia Khan, MD
Read More
Review Article
The Older Adult Living With Chronic Lymphocytic Leukemia: Implications for Oncology Providers, Patients, and Caregivers
Sandra E. Kurtin, PhDc, ANP-C, AOCN®
Read More
Appendix
Appendix
Compiled by Ali McBride, PharmD, BCOP, Andrew Garcia, PharmD, and Alyssa Hinchman, PharmD
Read More
Editorial
A Letter From The Guest Editor
Read More
Review Article
The Role of the Advanced Practitioner in Maintaining Adherence in Patients on Oral Oncolytics
Kimberly M. Hicks,(1) PharmD, MHA, Diane Cope,(2) PhD, ARNP-BC, AOCNP®, John Novak,(3) CHA, PA-C, and Susan Scherer,(4) RN, BSN, OCN
Read More
Editorial
The Rise of Genetic Testing in Managing Patients With Ovarian Cancer
Patrick J. Kiel, PharmD, BCPS, BCOP
Read More
Review Article
The Emerging Role of Molecular Testing in Ovarian Cancer
Patrick J. Kiel,(1) PharmD, BCPS, BCOP, Courtney B. Cortez,(2) NP, Cynthia L. Hunter,(3) MS, LCGC, and Jeanne M. Schilder,(1) MD
Read More
Editorial
The Rise of Genetic Testing in Managing Patients With Non–Small Cell Lung Cancer
Patrick J. Kiel, PharmD, BCPS, BCOP
Read More
Review Article
The Emerging Role of Molecular Testing in Non–Small Cell Lung Cancer
Patrick J. Kiel,(1),(2) PharmD, BCPS, BCOP, Liang Cheng,(1) MD, Anna Livers-Ertel,(3) ANP-BC, MSN, OCN®, and Gregory Durm,(2) MD
Read More
Editorial
Introduction
Heather Hampel, MS, LGC, Guest Editor
Read More
Review Article
Lynch Syndrome and Immunotherapy
Heather Hampel, MS, LGC, and Brianna Hoffner, MSN, ANP-BC, AOCNP®
Read More
Review Article
BRCA-Related Ovarian Cancers and the Role of PARP Inhibitor Therapy
Leigha Senter, MS, LGC, and Paula Anastasia, RN, MN, AOCN®
Read More
Continuing Education
CAR T-Cell Therapy: An Approach Whose Time Has Come
Read More
Continuing Education
The Latest Advances in CAR T-Cell Therapy for Refractory and Relapsed Lymphomas and Leukemias
Marco L. Davila, MD, PhD
Read More
Editorial
Letter From the Guest Editors
Read More
Editorial
Take a Deep Breath: More Treatment Options for Non–Small Cell Lung Cancer
Lisa Cordes, PharmD, BCACP, BCOP, and Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC
Read More
Review Article
Diagnosis of Lung Cancer
Marianne Davies, DNP, MSN, CNS, ACNP, AOCNP®, and Helen Shih, MSN, MPH
Read More
Review Article
Fundamentals of Lung Cancer Staging
Marianne Davies, DNP, MSN, CNS, ACNP, AOCNP®
Read More
Review Article
Predictive and Prognostic Biomarkers and Related Therapies in Non–Small Cell Lung Cancer
Samantha Schmidt, PharmD, and Grashma Vadakkel, PharmD(c)
Read More
Review Article
Supportive Care and Management of Treatment-Emergent Adverse Events With Targeted Therapy in Non–Small Cell Lung Cancer
Clell Hasenbank, PharmD
Read More
Review Article
Emerging Biomarkers in Non–Small Cell Lung Cancer
Melinda Oliver, BA, BSN, RN, MPAP
Read More
Review Article
Immunotherapy Mechanisms of Action in Non–Small Cell Lung Cancer
Beth Eaby-Sandy, MSN, CRNP, OCN®
Read More
Review Article
Unleashing the Immune System With Checkpoint Inhibitors in Non–Small Cell Lung Cancer: Clinical Review of Adverse Events
Sandra Cuellar, PharmD, BCOP
Read More
Review Article
Emerging Therapies in Non–Small Cell Lung Cancer: Clinical Trials With Novel Agents
Karen Oishi, MSN, APRN, AGPCNP-BC, OCN®
Read More
Tools and Technology
Resources for Patients With Non–Small Cell Lung Cancer and Their Caregivers and Providers
Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC
Read More
Appendix
Appendix
Lisa Cordes, PharmD, BCACP, BCOP
Read More
Editorial
Priming the Pump Task Force
Read More
Continuing Education
Continuing Education Information
Read More
Continuing Education
Meet the Team
Read More
Continuing Education
Managing the Care of Patients With HER2-Positive Breast Cancer: A Collaborative Practice Model
Angela DeMichele, MD, MSCE; Jennie Greco Lattimer, MSN, BSN, CRNP; and Rachel F.
Read More
Appendix
Appendix
Managing the Care of Patients With HER2-Positive Breast Cancer: A Collaborative Practice Model
Read More
Continuing Education
Continuing Education Information
Read More
Editorial
The Future is Bright
Sandra Kurtin, RN, MSN, AOCN®, ANP-C
Read More
Editorial
The Continuum of Care in Multiple Myeloma Redefined: Challenges and Opportunities
Sandra Kurtin, RN, MSN, AOCN®, ANP-C, Guest Editor
Read More
Review Article
Sequencing of Treatment and Integration of Clinical Trials
Beth Faiman,(1) PhD, MSN, APRN-BC, AOCN®, Charise Gleason,(2) MSN, NP-BC, AOCNP®, Kathleen Colson,(3) RN, BSN, BS, Ann McNeill,(4) RN, MSN, APN, and Donna Catamero,(5) ANP-BC, OCN®, CCRC, on behalf of the International Myeloma Foundation Nurse Leadership Board
Read More
Review Article
Palliative Care in Multiple Myeloma
Tiffany Richards,(1) MS, ANP, AOCNP®, and Kevin Brigle,(2) PhD, NP, on behalf of the International Myeloma Foundation Nurse Leadership Board
Read More
Prescriber's Corner
New Agents in the Treatment of Multiple Myeloma
Beth Faiman,(1) PhD, MSN, APRN-BC, AOCN®, Ali McBride,(2) PharmD, MS, BCPS, BCOP, Hollie Devine,(3) MSN, ANP-BC, Charise Gleason,(4) MSN, NP-BC, AOCNP®, and Sandra Kurtin,(5) RN, MSN, AOCN®, ANP-C, on behalf of the International Myeloma Foundation Nurse Leadership Board
Read More
Prescriber's Corner
Monoclonal Antibodies in the Treatment of Multiple Myeloma
Charise Gleason,(1) MSN, NP-BC, AOCNP®, Hollie Devine,(2) MSN, ANP-BC, Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, Deborah Doss,(4) RN, OCN®, and Sandra Kurtin,(5) RN, MSN, AOCN®, ANP-C, on behalf of the International Myeloma Foundation Nurse Leadership Board
Read More
Grand Rounds
Updates in the Diagnosis and Monitoring of Multiple Myeloma
Sandra Kurtin,(1) RN, MSN, AOCN®, ANP-C, Page Bertolotti,(2) RN, BSN, OCN®, Kevin Brigle,(3) PhD, NP, and Daniel Verina,(4) BS, BSN, MSN, ACNP-BC, on behalf of the International Myeloma Foundation Nurse Leadership Board
Read More
Practice Matters
Adherence, Persistence, and Treatment Fatigue in Multiple Myeloma
Sandra Kurtin,(1) RN, MSN, AOCN®, ANP-C, Kathleen Colson,(2) RN, BSN, BS, Joseph Tariman,(3) PhD, ANP-BC, Beth Faiman,(4) PhD, MSN, APRN-BC, AOCN®, and Elizabeth Finley-Oliver,(5) RN, BSN, OCN, on behalf of the International Myeloma Foundation Nurse Leadership Board
Read More
Tools and Technology
Resources for Patients and Caregivers With Multiple Myeloma and Their Providers
Kevin Brigle, PhD, NP, on behalf of The International Myeloma Foundation Nurse Leadership Board
Read More
Appendix
Multiple Myeloma Treatment Options for Newly Diagnosed, Relapsed, and Refractory Disease
Kimberly Noonan,(1) RN, ANP, AOCN®, Teresa S. Miceli,(2) RN, BSN, OCN®, Patricia Mangan,(3) RN, MSN, APRN-BC, and Sandra Rome,(4) RN, MN, AOCN®, CNS, on behalf of the International Myeloma Foundation Nurse Leadership Board
Read More
Continuing Education
Continuing Education Information
Read More
Meeting Report
Meet The Panel
Read More
Meeting Abstract
Methotrexate and Fluorouracil Toxicities: What Advanced Practitioners in Oncology Need to Know
Read More
Meeting Abstract
Case Studies: Collaborative Practice In Action
Read More
Meeting Abstract
Questions Answered About Glucarpidase
Read More
Meeting Abstract
Questions Answered About Uridine Triacetate
Read More
Continuing Education
Continuing Education Information
Read More
Editorial
Collaborative Practice Enhances Supportive Care in Cancer: Chemotherapy-Induced Nausea and Vomiting
Rita Wickham, PhD, RN, AOCN® Sally Barbour, PharmD, BCOP, CPP Teresa Scardino, RPA-C, MPAS
Read More
Review Article
Risks for Chemotherapy-Induced Nausea and Vomiting: Capturing Relevant Data
Teresa Scardino, RPA-C, MPAS
Read More
Review Article
Actualizing Standards of Care for Chemotherapy-Induced Nausea and Vomiting
Sally Barbour, PharmD, BCOP, CPP
Read More
Review Article
Managing Chemotherapy-Induced Nausea and Vomiting: Past, Present, and Future
Rita Wickham, PhD, RN, AOCN®
Read More
Grand Rounds
Managing Chemotherapy-Induced Nausea and Vomiting: An Adaptable, Collaborative Approach for a Patient With Colon Cancer
Rita Wickham, PhD, RN, AOCN®, Sally Barbour, PharmD, BCOP, CPP, and Teresa Scardino, RPA-C, MPAS
Read More
Review Article
Relapsed or Relapsed/Refractory Multiple Myeloma
Sandra E. Kurtin, RN, MS, AOCN®, ANP-C
Read More
Prescriber's Corner
Carfilzomib
J. Michael Vozniak, PharmD, BCOP
Read More
Review Article
The Side Effect Profile of Carfilzomib: From Clinical Trials to Clinical Practice
Laura McBride, RN, BSN, OCN®, CCRP, and Christine O. Samuel, RN, BSN, OCN®, CCRP
Read More
Grand Rounds
Treatment of Patients With Multiple Myeloma: A Relapsed and Refractory Case Study
Sandra E. Kurtin, RN, MS, AOCN®, ANP-C
Read More
Review Article
Treatment With Carfilzomib: A Promising Future for Multiple Myeloma
Donna Catamero, ANP-BC, OCN®, CCRC, and Charise Gleason, MSN, ANP, AOCNP®
Read More
Continuing Education
Continuing Education Information
Read More
Review Article
Monitoring, Treatment Resistance, and Treatment Failure in CML: Breaking Barriers to Improved Outcomes
Jorge Eduardo Cortes, MD(1). John M. Goldman, DM, FRCP, FRCPath, FMedSci(2), and Timothy P. Hughes, MD, MBBS(3); Faculty Perspectives by Patricia S. Ault, RN, FNP(1), and Mary Beth Rios, CCRP, RN(1)
Read More
Continuing Education
Continuing Education Information
Read More
Editorial
Managing Hematologic Malignancies: The Balancing Act
Sandra Kurtin, RN, MS, AOCN®, ANP-C
Read More
Review Article
Current Approaches to the Diagnosis and Management of Myelodysplastic Syndromes
Sandra Kurtin, RN, MS, AOCN®, ANP-C
Read More
Review Article
Risk Stratification and Management of Acute Myeloid Leukemia
Jean A. Ridgeway, MSN, APN, NP-C, AOCN®
Read More
Review Article
Update on the Management of Follicular Lymphomas
Amy Goodrich, MSN, CRNP
Read More
Review Article
Management of Multiple Myeloma and Serious Side Effects
Elizabeth Bilotti, MSN, RN, APN, OCN®
Read More
Continuing Education
Continuing Education Information
Read More
Review Article
Oral Mucositis: Addressing the Causes, Challenges, and Clinical Management
Carrie F. Daly, MS, RN, AOCN®, and Annette M. Quinn, MSN, RN
Read More
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our
Privacy Policy
to learn more.